# Nuvectis Pharma, Inc. (NVCT): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/nvct for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020.

## Quote & Key Metrics

As of 2026-10-30:

| Metric | Value |
|---|---|
| Price | $18.48 USD |
| Market Cap | $603.3M |
| P/E (TTM) | — |
| EPS (TTM) | −$1.31 |
| 52-Week Range | $5.55 – $29.28 |
| Dividend Yield (TTM) | — |

## Dividend

NVCT has no dividend payment history in our records.

## Frequently Asked Questions

### What does Nuvectis Pharma, Inc. do?

Nuvectis Pharma, Inc. (NVCT) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is NVCT's market cap?

Nuvectis Pharma, Inc. (NVCT) has a market capitalization of approximately $603.3 million, as of October 30, 2026, based on the most recent share price and shares outstanding.

### Does NVCT pay a dividend?

No, Nuvectis Pharma, Inc. (NVCT) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is NVCT profitable?

Nuvectis Pharma, Inc. (NVCT) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has NVCT ever paid a dividend?

No. Dividend Data's records show no dividend payments from Nuvectis Pharma, Inc. (NVCT). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/nvct
- Dividend history & safety: https://www.dividenddata.com/stocks/nvct/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/nvct/earnings
- Financial statements: https://www.dividenddata.com/stocks/nvct/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/nvct/valuation
- Peer comparison: https://www.dividenddata.com/stocks/nvct/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.